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ABSTRACT
Objectives: This paper reports secular trends in
diabetes in pregnancy in Victoria, Australia and
examines the effect of including or excluding women
with pre-existing diabetes on gestational diabetes
(GDM) prevalence estimates.
Design: Population-based observational study.
Setting: All births in Victoria, Australia between 1999
and 2008
Participants: 634 932 pregnancies resulting in a birth
registered with the Victorian Perinatal Data Collection
Outcome measures: Crude and age-standardised
secular trends in pre-existing diabetes and GDM
prevalence; secular GDM trends by maternal birthplace;
effects on GDM prevalence of including and excluding
pre-existing diabetes from the denominator.
Results: Of the 634 932 pregnancies, 2954 (0.5%)
occurred in women with pre-existing diabetes and
29 147 (4.6%) were complicated by GDM. Mean
maternal age increased from 29.7 years in 1999 to
30.8 years in 2008. GDM prevalence increased in most
maternal age groups. In 2008, age-standardised GDM
prevalence was 31% higher than in 1999; secular
increases were greater for Australian-born non-
Indigenous (29% increase) than immigrant women
(12.3% increase). The annual number of pregnancies in
women with pre-existing diabetes almost doubled from
1999 to 2008 and prevalence increased from 0.4% to
0.6%. However, including or excluding pre-existing
diabetes had little effect on GDM prevalence estimates.
Conclusions: Pre-existing diabetes and GDM
prevalence increased in Victoria between 1999 and
2008 and rising maternal age does not fully explain
these trends. These findings have important
implications for preventive initiatives. Including or
excluding small numbers of women with pre-existing
diabetes resulted in minimal changes in GDM estimates.
As pre-existing diabetes in young women increases, this
methodological issue will likely become important.
INTRODUCTION
True pregnancy-induced hyperglycaemia
differs from pre-existing maternal diabetes.
Pregnancy is diabetogenic: insulin resistance
increases with advancing gestation. Maternal
insulin secretion normally increases in
response; if insufﬁcient to overcome the
insulin resistance, hyperglycaemia occurs.
Pre-pregnancy glycemic control is usually
restored after delivery.1 This differs from pre-
existing maternal type 1 and type 2 diabetes,
which are neither induced by pregnancy nor
resolve post-partum. Any form of diabetes in
pregnancy increases risk of a range of
adverse maternal and neonatal outcomes;
risk of some such complications is greater
with pre-existing diabetes.2 3 Moreover, pre-
existing maternal diabetes in pregnancy pre-
sents particular management issues.4
By deﬁnition, gestational diabetes mellitus
(GDM) describes glucose intolerance that
begins or is ﬁrst recognised during preg-
nancy.5 Therefore, GDM encompasses both
true pregnancy-induced hyperglycaemia and
diabetes predating pregnancy but previously
undiagnosed. Pre-existing diabetes is con-
ﬁrmed if postpartum testing demonstrates
Strengths and limitations of this study
▪ This study reports secular trends in Australian
population-level prevalence of pre-existing dia-
betes in pregnancy and gestational diabetes
(GDM) using data collected over 10 years from a
comprehensive perinatal database that captures
virtually all births in the state. Recording of GDM
and pre-existing diabetes in this database have
been shown to be highly accurate.
▪ This paper also examines an important epidemio-
logical issue of the effect of including or exclud-
ing the growing group of women with
pre-existing diabetes on GDM prevalence esti-
mates. This methodological consideration is likely
to become increasingly important as the number
of women with pre-existing diabetes increases.
▪ As this study uses population-level administrative
data it is not possible to identify unscreened
pregnancies and screening practice may have
changed over time.
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persistent dysglycaemia fulﬁlling non-pregnancy diagnos-
tic thresholds for diabetes.6 However, antenatal records
and birth reports, commonly used to ascertain GDM
prevalence, are completed before these tests are con-
ducted and their results known.
Prevalence of diagnosed pre-existing diabetes among
pregnant women is generally increasing.3 7–12 Recent
secular increases in GDM burden have also been docu-
mented in Manitoba13 and Ontario, Canada,11 Tianjin,
China14 and Bahrain.15 From across the USA there are
reports of increasing GDM,9 12 16 17 increases followed
by a levelling off,18 no temporal changes7 and ﬂuctua-
tions in disease burden over time.19 In Australia, over
recent decades rising GDM burden has been
reported;3 20–23 trends in diabetes in pregnancy among
Indigenous Australian women are inconsistent.10 20 24–26
There are several methodological issues surrounding
GDM epidemiology, including denominator selection.27
For example, Australian GDM studies have included in the
denominator all pregnant women/births/conﬁne-
ments,2 3 10 20 24–26 28 only singleton pregnancies,29 30 only
screened/tested pregnancies,22 31 excluded women with
pre-existing diabetes23 30 and/or reported prevalence of
all forms of diabetes in pregnancy collectively.10 24 26
Similar methodological variation exists internationally.
The International Association of Diabetes and
Pregnancy Study Group (IADPSG) recognises the issues
associated with including women with pre-existing dia-
betes together with those with ‘true’ GDM.32 New
IADPSG recommendations advise that all or high-risk
women without known glucose abnormalities undergo
fasting plasma glucose (FPG), random plasma glucose or
glycated haemoglobin A1c (HbA1c) testing at the ﬁrst
antenatal visit. This is to identify ‘overt’ diabetes (FPG
≥7.0 mmol/L or HbA1c ≥6.5% or random plasma
glucose ≥11.1 mmol/L and conﬁrmed with FPG or
HbA1c result) and early-onset GDM.32 The Australasian
Diabetes in Pregnancy Society (ADIPS) recommends that
high-risk women have a 75 g oral glucose tolerance test
(OGTT) as soon as possible after conception to detect
GDM.6 Both authorities recommend universal testing of
remaining women using OGTTat 24–28 weeks to identify
additional cases.6 32 The FPG level considered diagnostic
of GDM will be reduced from ≥5.5 to ≥5.1 mmol/L, and
the 2 h plasma glucose threshold is to increase from ≥8.0
to ≥8.5 mmol/L.6 These guidelines are expected to sub-
stantially increase the number of women diagnosed with
GDM.33 The IADPSG and ADIPSG diagnostic criteria rec-
ommend dispensing with the Glucose Challenge Test
(GCT). The GCT misses 25% of GDM cases and conse-
quently adoption of this step alone is likely to be a signiﬁ-
cant contributor to the increased diagnostic rates of
GDM.34 The IADPSG recommendations are also
intended to increase detection of pre-existing diabetes.
As diagnosed pre-existing diabetes rises, the methodology
used to calculate GDM prevalence may inﬂuence the esti-
mates due to differing denominator sizes, particularly
among ethnic groups and in settings where pre-existing
diabetes prevalence is high. Such variation has a range of
potential implications, including for funding and health
service planning.
No recent population-level Australian studies examine
longitudinal trends in pre-existing maternal diabetes,3
and few report recent trends in burden of GDM
overall20 23 or among various migrant groups.20 Using
data routinely collected over 10 years from the state of
Victoria, Australia, we investigated ﬁrst, secular trends in
prevalence of pre-existing diabetes in pregnancy;
second, trends in GDM burden; and ﬁnally, the effects
of including and excluding women with pre-existing dia-
betes on GDM prevalence estimates.
METHODS
The Victorian Perinatal Data Collection (VPDC) is a
population-based surveillance system, maintained by the
Consultative Council on Obstetric and Paediatric Mortality
and Morbidity, Victorian Department of Health.
Information is routinely collected on all births of at least
20 weeks’ gestation (or if gestation is not known, birth-
weight of at least 400 g). Birth report forms are completed
at delivery by a clinician; notiﬁcation of births to the VPDC
by hospitals, birthing centres and private midwife practi-
tioners is mandatory. Therefore, the database is consid-
ered to completely capture virtually all births in Victoria
that fulﬁl reporting requirements.
De-identiﬁed data were extracted for all notiﬁed births
that occurred in Victoria between 1 January 1999 and 31
December 2008. For pregnancies yielding more than one
birth (ie, twins or more), only the birth record for the ﬁrst-
born infant was extracted. Each entry therefore represents
one pregnancy. As women may have had more than one
pregnancy during the study period, the same woman may
be represented in the data set multiple times. Variables
used in this analysis were year of delivery, maternal age at
delivery (categorised into age groups of ≤24 years, 25–29,
30–34, 35–39, ≥40 years), parity, diabetes status (GDM, pre-
existing maternal diabetes not further speciﬁed, no dia-
betes), maternal Aboriginal and Torres Strait Islander (ie,
Indigenous) status and maternal country of birth. Maternal
country of birth was reclassiﬁed into geographically-based
regions using the Australian Bureau of Statistics’ Standard
Australian Classiﬁcation of Countries. This classiﬁcation
scheme includes Australia in the group Oceania and
Antarctica. However, we categorised Australian-born women
separately into two additional groups: Australian-born
Indigenous and Australian-born non-Indigenous.
Maternal diabetes status was assigned based on
whether the clinician completing the notiﬁcation form
ticked the checkboxes for GDM or pre-existing maternal
diabetes. Recording of GDM and pre-existing diabetes in
the VPDC are reported to be 99.4% and 99.8% accurate,
respectively.35 Over the study period, Australian guide-
lines recommended universal offer of GDM screening,
with selective screening of high-risk women considered
appropriate in resource limited or low prevalence
2 Abouzeid M, et al. BMJ Open 2014;4:e005394. doi:10.1136/bmjopen-2014-005394
Open Access
group.bmj.com on December 10, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
settings. Screening is performed at 26–28 weeks gesta-
tion and a positive result is a 1 h venous plasma glucose
level of ≥7.8 mmol/L after a morning, non-fasting 50 g
glucose load or ≥8 mmol/L after a morning, non-fasting
75 g glucose load. Conﬁrmation of GDM diagnosis
after a positive screening test requires an OGTT at 26–-
30 weeks gestation with venous plasma glucose levels of
≥5.5 mmol/L at 0 h and/or ≥8 mmol/L at 2 h.5
Statistical analyses
Maternal demographic characteristics over time were
examined using descriptive statistics. Crude and
age-standardised annual prevalence rates of pre-existing
diabetes, GDM and all diabetes were calculated as a per-
centage of total annual pregnancies, using direct stand-
ardisation to the maternal age structure of the entire
study population. GDM prevalence rates over time were
further examined by maternal age group and region of
birth. Small numbers precluded similar analyses for pre-
existing diabetes. To examine the effect of denominator
variation on overall GDM prevalence estimates, annual
GDM prevalence rates were also calculated after exclud-
ing from the denominator pregnancies in women with
pre-existing diabetes.
Women who had more than one pregnancy during the
study period were included in each year that they deliv-
ered. This approach, coupled with the fact that having dia-
betes of any form in pregnancy increases the likelihood of
diabetes in subsequent pregnancies, meant that observa-
tions were not necessarily independent. As the assumption
of independence that underlies tests for linear trend was
not fulﬁlled, such analyses were not performed, and
age-standardised prevalence rates were considered signiﬁ-
cantly different if 95% CIs did not overlap. For sensitivity
analysis, annual prevalence rates of pre-existing diabetes,
GDM and all diabetes were calculated after restricting to
women giving birth for the ﬁrst time, and tests for linear
trend were performed for this subgroup.
Data were analysed using Stata V.11.0. Permission to
access and analyse data was granted by the Consultative
Council on Obstetric and Paediatric Mortality and
Morbidity, Victorian Department of Health. The Flinders
University Social and Behavioural Research ethics commit-
tee exempted this study from requiring ethics approval, as
it involved analysis of existing de-identiﬁed data.
RESULTS
During the 10-year study period, there were 634 932
pregnancies resulting in a birth registration with the
VPDC (table 1). In 2008 there were 15.7% more preg-
nancies than in 1999. Mean maternal age increased
from 29.7 years in 1999 to 30.8 years in 2008. The
number of births to women aged 40 years and over was
91.3% higher in 2008 than in 1999.
Maternal region of birth was known for 99.7%
(n=632 805) of pregnancies, of which 74.6% occurred in
Australian-born women of non-Indigenous descent
(table 1). There was an overall trend of an increasing
number of pregnancies in women born in all regions,
with the exception of North-West Europe and Southern
and Eastern Europe where there was a decline. The
trend of increasing pregnancies was particularly strong
in women from Southern and Central Asia (table 1).
The number of women becoming pregnant for the ﬁrst
time increased during the study period with 5486
(22.1%) more ﬁrst pregnancies recorded in 2008 com-
pared with 1999 (table 1).
Diabetes in pregnancy
In 2008, 6.1% of all pregnancies were complicated by
some form of diabetes, compared with 4.3% in 1999
(table 2). Each year, pregnancies occurring in older
women (those aged 35–39 years and 40 years or older)
had higher prevalence of any form of diabetes than
pregnancies in younger women (data not shown).
Prevalence of pre-existing maternal diabetes in pregnancy
Between 1999 and 2008, 2954 pregnancies (0.5%)
occurred in women with known pre-existing diabetes.
The prevalence rate of pre-existing diabetes increased
from 0.4% to 0.6%, representing an increase of 50%
over the study period and there was little difference
between the crude and age-standardised estimates
(ﬁgure 1A). The absolute annual number of pregnan-
cies in women with pre-existing diabetes almost doubled
over this period.
For the entire 10-year period, the greatest absolute
number of pregnancies in women with pre-existing dia-
betes occurred in Australian-born non-Indigenous
women, and for the migrant groups, in those born in
South-East Asia and Southern and Central Asia; pre-
existing diabetes prevalence rates were however highest
in pregnancies among women born in Southern and
Central Asia and Sub-Saharan Africa (data not shown).
Prevalence of GDM
Of all pregnancies in Victoria from 1999 to 2008, 29 147
(4.6%) were complicated by GDM. Overall, the annual
number of GDM pregnancies increased by 64% between
1999 and 2008. Increases in the absolute number of
GDM pregnancies over time were apparent in all but the
youngest group of women (ﬁgure 1B). GDM also
increased as a proportion of total pregnancies, such that
in 2008, the age-standardised GDM prevalence rate was
31% higher than in 1999 (table 2). Over the study
period, crude GDM prevalence rates tended to increase
in pregnancies among women in most age groups
(ﬁgure 1C). Analysis of data from women in their ﬁrst
pregnancy who did not have pre-existing diabetes
revealed a signiﬁcant positive linear trend in the preva-
lence of the crude (p<0.001) and age-standardised
(p<0.001) rates of GDM over the study period.
Considerable differences in GDM prevalence rates
existed by maternal region of birth (ﬁgure 2).
Prevalence increased over time, both among Australian-
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Table 1 Maternal demographic characteristics for pregnancies yielding births notified to the Victorian Perinatal Data Collection by year of delivery, Victoria 1999–2008*
Year of delivery
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Total
1999–2008
Maternal age group (N)
≤24 years 9768 9363 9270 9152 8903 8644 8895 9445 9619 9762 92 821
25–29 years 19 074 18 537 17 283 16 535 16 241 15 740 16 213 16 739 17 652 17 583 171 597
30–34 years 20 485 20 957 21 667 22 615 23 050 23 119 23 748 24 447 24 475 24 021 228 584
35–39 years 9456 9839 9895 10 563 10 796 11 534 12 765 13 859 15 137 15 420 119 264
≥40 years 1641 1731 1879 1981 2117 2241 2393 2658 2854 3139 22 634
Total 60 424 60 427 59 994 60 846 61 107 61 278 64 014 67 148 69 737 69 925 634 900
Percentage of aged >30 52.27 53.83 55.74 57.78 58.85 60.21 60.78 61.01 60.89 60.89 58.33
Parity
1 24 879 25 242 24 662 25 511 26 015 26 328 27 568 29 024 30 066 30 362 269 657
2 or higher 35 545 35 185 35 332 35 335 35 091 34 950 36 446 38 124 39 671 39 563 365 242
Region of birth†
Australia (non-Indigenous) 45 573 45 258 45 236 46 076 46 014 45 985 47 715 49 764 50 342 50 042 472 005
Oceania 1496 1488 1626 1566 1663 1636 1685 1838 1846 1974 16 818
North-West Europe 2565 2438 2353 2275 2134 2127 2156 2250 2400 2213 22 911
Southern and Eastern Europe 1821 1700 1595 1527 1611 1440 1468 1477 1562 1451 15 652
North Africa and Middle East 1630 1573 1537 1581 1669 1684 1889 1979 1997 2146 17 685
South-East Asia 3234 3667 3304 3364 3506 3419 3427 3598 4053 4113 35 685
North-East Asia 1158 1256 1080 1125 1061 1122 1148 1305 1691 1704 12 650
Southern and Central Asia 1125 1184 1194 1228 1346 1512 1793 2195 2675 3251 17 503
Americas 651 693 721 734 691 744 806 840 864 846 7590
Sub-Saharan Africa 708 765 863 854 905 990 1152 1145 1260 1248 9890
Australia (Indigenous) 397 325 358 366 326 394 463 501 628 658 4416
*Includes women who had more than one pregnancy during the study period; 32 births had no information on age of mother and one birth had no information on parity.
†Of the 634 932 registered births 2127 recorded the maternal region of birth as unknown.
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born non-Indigenous women and overseas-born women
considered collectively. However, the same pattern was
not evident when considering Indigenous Australians
and each migrant group individually. The extent of the
changes in GDM prevalence rates over time varied by
migrant origin status. In Australian-born non-Indigenous
women, age-standardised GDM prevalence in 2007 and
2008 was 29% higher than in 1999 and 2000 (4% vs
3.1%), whereas among all overseas-born women collect-
ively, prevalence increased by 12.3% between these two
time periods (8.2% vs 7.3%; ﬁgure 2) with differences
between the various groups.
Effect of denominator variation
Including or excluding women with pre-existing diabetes
had little effect on GDM prevalence rates overall
(table 2). Estimates were generally similar, albeit lower,
when considering only women in their ﬁrst pregnancy
(see online supplementary table S1). Including or
excluding women with pre-existing diabetes also had
very little effect on GDM prevalence rates by maternal
region of birth (data not shown).
DISCUSSION
Prevalence of both pre-existing diabetes in pregnancy
and GDM increased in Victoria, Australia over the
period 1999–2008. The number of births to older
mothers increased over the study period, almost doub-
ling for those aged 40 years and over. However,
age-standardising had little effect on prevalence rates,
and GDM prevalence increased within most maternal
age groups, indicating that rising maternal age does not
fully explain the upward trends. GDM prevalence
increased to a greater extent in pregnancies among
Australian-born non-Indigenous women compared with
rates in all overseas-born women. Consistent with exist-
ing knowledge,20 22 23 28–31 pregnancies occurring in
women born throughout Asia and in North Africa and
the Middle East had the highest GDM rates.
Similar to recent reports of rising trends in GDM
burden nationally20 and in the multiethnic state of New
South Wales,3 23 we noted a pronounced increase in
overall GDM prevalence in Victoria from 1999 to 2008.
This may reﬂect secular increases in obesity prevalence
in the general population36; effects of obesity could not
be examined as maternal pre-pregnancy body mass
index (BMI) was not recorded in the VPDC during the
study period. BMI trend data in Australian obstetric
patients are sparse and generally from single centres. 37
Maternal BMI has been recorded in the VPDC since
2009; further research is required in the Australian
context when population-level obstetric BMI trend data
become available.
In our study GDM prevalence increased across most
maternal age groups. This and the fact that results were
generally similar when restricting to primiparous women
indicates that factors other than those examined in this
study likely largely account for the observed trends. In
the general Australian population, prevalence of over-
weight/obesity has increased across most age groups
over time38 and this may be contributing to the rising
GDM prevalence observed in our study among most
groups including the younger mothers. Rising GDM
prevalence may also reﬂect increases in pre-existing but
previously undiagnosed diabetes; as postnatal OGTT
results were not available, the extent to which this is the
case cannot be established. Additionally, GDM ascertain-
ment may be inﬂuenced by systemic factors, which them-
selves may change over time. In particular, screening
and diagnostic practices and uptake rates will inﬂuence
case detection. For example, after introduction of uni-
versal OGTT testing in a regional hospital in northern
Australia, testing rates in Indigenous Australian women
increased from 31.4% in 2006 to 65.6% in 2008 and
GDM rates tripled.26
This study has demonstrated that migrant disparities in
GDM prevalence appear to be diminishing, but in a con-
cerning rather than desirable manner: increases in GDM
prevalence rates over time were most pronounced in
Australian-born non-Indigenous women, among whom
Table 2 Crude and age-standardised prevalence of GDM by year of delivery and denominator, Victoria 1999–2008
GDM/all pregnancies (%)
GDM/all pregnancies less
pre-existing (%)
All forms of diabetes in
pregnancy (%)
Year n (all births) n (GDM) Crude Age-standardised Crude Age-standardised* Crude Age-standardised
1999 60 424 2356 3.90 4.10 (3.94–4.26) 3.91 4.11 (3.95–4.28) 4.27 4.48 (4.31–4.65)
2000 60 431 2548 4.22 4.38 (4.21–4.55) 4.23 4.39 (4.23–4.56) 4.56 4.73 (4.56–4.90)
2001 59 997 2593 4.32 4.43 (4.26–4.60) 4.34 4.45 (4.28–4.61) 4.71 4.82 (4.65–5.00)
2002 60 847 2752 4.52 4.58 (4.41–4.74) 4.54 4.59 (4.43–4.76) 4.95 5.00 (4.83–5.18)
2003 61 111 2611 4.27 4.29 (4.13–4.46) 4.29 4.31 (4.15–4.47) 4.71 4.73 (4.56–4.90)
2004 61 283 2547 4.16 4.13 (3.97–4.29) 4.17 4.15 (3.99–4.31) 4.61 4.58 (4.42–4.75)
2005 64 022 3027 4.73 4.66 (4.50–4.83) 4.75 4.69 (4.52–4.85) 5.24 5.17 (5.00–5.34)
2006 67 150 3295 4.91 4.82 (4.66–4.98) 4.93 4.85 (4.69–5.01) 5.43 5.34 (5.17–5.51)
2007 69 738 3559 5.10 4.98 (4.82–5.14) 5.13 5.01 (4.85–5.17) 5.67 5.53 (5.37–5.70)
2008 69 929 3859 5.52 5.37 (5.21–5.54) 5.55 5.40 (5.24–5.57) 6.12 5.96 (5.78–6.13)
*Age-standardised to the age structure of the entire study population for the 10 year period, excluding those with pre-existing diabetes.
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Figure 1 (A) Crude and
age-standardised prevalence of
pre-existing maternal diabetes in
pregnancy by year of delivery,
Victoria 1999–2008; (B) Crude
number of GDM cases by year of
delivery and maternal age group,
Victoria 1999–2008; (C) Crude
GDM prevalence rates* by year of
delivery and maternal age group,
Victoria 1999–2008. *The
denominator used to calculate
prevalence of GDM is all
pregnancies.
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GDM prevalence was converging with the higher rates in
overseas-born mothers. A similar phenomenon closing
the gap in burden of diabetes in pregnancy between high
rate Indigenous and increasingly higher rate
non-Indigenous Australian women has also been previ-
ously described.20 24 The desired key to reducing overall
disease burden and sociocultural inequities is to close the
gap by reducing prevalence among high-risk groups and
to contain and ideally reduce the prevalence among
lower risk groups. Our ﬁndings differ from recent
national reports that GDM increased to a similar extent
among Australian-born (23% increase) and all overseas-
born mothers collectively (24% increase), with differen-
tial increases between individual migrant groups, for the
period 2000–2001 and 2005–2006.20 That GDM burden
in Victoria increased over time among all migrant groups
collectively but not individually may be due to the fact
that the proportion of mothers born in high prevalence
regions and giving birth in Victoria has increased over
time,39 but our study may have been underpowered to
detect differences within individual migrant groups.
Alternatively, it is possible that risk factor distribution or
screening uptake may have changed more over time for
some groups than others, or that there is a difference in
the proportion of diagnosed to undiagnosed diabetes
between migrants and local-born women. Future research
should seek to conﬁrm our results and investigate under-
lying causes.
In contrast to earlier ﬁndings,3 recent work suggests
that in the Australian obstetric population, pre-existing
type 2 diabetes is now as common as type 1 diabetes,2
and even the predominant form of pre-existing diabetes
in pregnancy.40 The increasing number of pregnancies
in women with pre-existing diabetes observed in our
study is consistent with international ﬁndings7–9 11 12
and reinforces the urgent need for population-level pre-
ventive initiatives to address the growing public health
problem of diabetes in the young. These upward trends
are likely to continue, particularly in the setting of the
obesity and type 2 diabetes epidemics in the general
population,36 evidence of earlier onset of type 2 dia-
betes, trends toward delayed childbearing39 and intro-
duction of new antenatal screening guidelines6 32 that
will increase case detection.
There are a number of strengths to this study. This is
one of few papers to report secular trends in Australian
population-level prevalence of pre-existing diabetes in
pregnancy3 and to our knowledge, the only one to
present data spanning a decade. It is also one of few
Australian studies, and the ﬁrst from Victoria since the
early 1990s, to report ethnospeciﬁc secular trends in
GDM prevalence. This is important because of Australia’s
diverse and evolving multiethnic demography. Others
have reported their GDM prevalences after excluding
pre-existing diabetes as sensitivity analysis19 but as far as
we are aware, our paper is the ﬁrst to speciﬁcally examine
using a single database the effect of including or exclud-
ing the growing group of women with pre-existing dia-
betes on GDM prevalence estimates, in important
subgroups such as region of birth where denominator
variation plausibly might have an effect. This methodo-
logical issue is likely to become increasingly relevant, with
implications for service planning and delivery and pre-
ventive efforts worldwide.
Figure 2 Age-standardised GDM prevalence rates* by maternal region of birth and year of delivery, Victoria 1999–2008.
*The denominator used to calculate prevalence of GDM is all pregnancies.
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The data source was a comprehensive population-level
perinatal data collection. Case ascertainment depends
on accurate completion of birth report forms—training
manuals exist to facilitate this. Data collection forms did
not change over the study period, with GDM and pre-
existing diabetes status recorded consistently using
checkboxes; this reduces the likelihood of ascertainment
bias over time.
Study limitations should be noted. Australian guide-
lines over the study period recommended universal
screening for GDM, with selective screening to be consid-
ered in settings with limited resources or low GDM
burden.5 As it is not possible to identify unscreened preg-
nancies in our data, all pregnancies yielding births that
were reported to the VPDC during the study period were
included in this analysis. Some women may not have
been tested for GDM, so our rates are minimum esti-
mates. Screening practice may have varied between clini-
cians and centres. For example, in 1999 there was
considerable variation in GDM testing in Australian hos-
pitals, including differences in the universal versus select-
ive offer of screening and the testing protocols used.41
Testing practices within centres may also have changed
over time.26 To enable identiﬁcation of screened preg-
nancies, we suggest that information on diabetes testing
status should be collected in perinatal data sets. Finally,
the region of birth classiﬁcations used in this study were
necessarily broad and may mask heterogeneity within
and between groups. Women may have been born in
Australia but have the behavioural and biological risk
factor proﬁles of their ethnic group of origin; ethnicity
data are not captured in the VPDC so it is not possible to
ascertain the extent to which this is the case.
In summary, prevalence of both pre-existing diabetes
and GDM increased among the Victorian obstetric popu-
lation between 1999 and 2008 and these increases are not
fully explained by rising maternal age. GDM prevalence
increased at a greater rate among Australian-born
non-Indigenous women than among migrant women.
These ﬁndings have important implications across all
levels of the healthcare system, from the primary preven-
tion sphere to pre-pregnancy counselling and antenatal
clinical service provision, through to postnatal manage-
ment of both mother and infant and tertiary prevention
and monitoring. As such, these results have clear implica-
tions for clinicians, who need to be aware of the sociocul-
tural distribution of GDM and actively managing women
at risk. This information is also important for policy-
makers and the public health profession, both to guide
preventive initiatives and to facilitate health service plan-
ning in the face of an increasing morbidity burden for
mothers and offspring as prevalence of GDM and pre-
existing diabetes increase. Given the health risks con-
ferred on infants of pregnancies complicated by diabetes,
addressing the rising burden of diabetes of any form in
pregnancy is essential if we are to break the cycle of inter-
generational diabetes transmission and reverse the direc-
tion and slope of trend graphs in future.
Finally, there has been debate surrounding many
aspects of GDM epidemiology, but the issue of denomin-
ator variation is one that appears to have been over-
looked, yet warrants consideration. Although having
negligible effect in our data set given low rates of pre-
existing diabetes, to include pre-existing diabetes in the
denominator could potentially underestimate GDM
prevalence; to exclude pre-existing cases could underesti-
mate the total burden of diabetes in pregnancy. These
issues should come to the attention of expert groups:
a consistent approach is required, in order to accurately
gauge disease burden, compare prevalence within and
between populations, and monitor trends. Perhaps the
best approach is to report prevalence of both GDM and
pre-existing diabetes separately. Particularly given the
looming rise in diagnosed cases of pre-existing disease,
measurement methodology will increasingly matter.
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